PB Fintech Shares Drop 48% in Six Days Amid IRDAI Commission Reforms

Shares of PB Fintech, the parent company behind popular insurance platforms Policybazaar and Paisabazaar, have experienced a steep decline over the past six trading sessions. The stock price has plunged by approximately 48 percent during this period, reflecting investor concerns about the impact of upcoming regulatory changes in the insurance sector.

The stock reached its lowest point in the last year at ₹965 on October 1, marking a drop of more than 50 percent from its 52-week peak of ₹1,963 recorded in December of the previous year. When viewed over a longer timeline, PB Fintech shares have fallen 42 percent in three months and 41 percent over the past year, signaling persistent pressure on the company’s valuation.

The sharp sell-off comes amid new proposals from the Insurance Regulatory and Development Authority of India (IRDAI) aimed at restructuring how insurance commissions and distribution fees are handled. These reforms target greater transparency, cost reduction for insurance buyers, and stricter controls on distribution practices, which are expected to alter the revenue models for intermediaries like PB Fintech.

Understanding the IRDAI Proposed Changes

The IRDAI draft guidelines propose several major reforms. Key among them are adjustments to the Expenses of Management (EoM), segment-specific commission caps, and prohibitions on certain sales tactics known as dark patterns. One notable change is the requirement for insurers to disclose product features and pricing without demanding upfront personal information from potential customers.

The regulator also plans increased transparency through mandatory disclosure of commission rates within policy documents, alongside specific modifications affecting motor insurance. The proposed reduction in commissions across health, motor, and term insurance lines has sparked concerns about shrinking margins for insurance intermediaries.

For PB Fintech, these changes could directly impact profitability, particularly in its general insurance segment and its point-of-sales person (POSP) distribution model. Lower commission rates threaten to reduce take-rates, challenging the company’s current earnings framework.

Brokerage Firms Adjust Earnings and Valuations

Financial analysts have responded to these developments by revising PB Fintech’s earnings forecasts and stock valuations downward. Bernstein, an international brokerage, has cut its price target for PB Fintech by 53 percent, from ₹2,310 to ₹1,085, while maintaining an Outperform rating. This new target suggests a modest 11 percent upside from the stock’s recent close of ₹980 on October 1.

Bernstein’s analysts explain that their lowered estimates reflect the significant negative impact expected from the proposed commission cuts. They describe the next 18 months as a critical period for PB Fintech, during which the company must adapt its business model to survive under the new rules. Although Bernstein anticipates growth and margin improvements beyond fiscal year 2028, it warns that the POSP business may have to scale down significantly.

The brokerage predicts that the reduced take-rates for general insurance will not cover existing costs, forcing PB Fintech to either downsize this segment or explore alternative business models to offset losses, especially in health insurance. Bernstein has also trimmed its net income forecast for fiscal year 2030 to ₹2,000 crore from ₹3,200 crore and lowered its earnings per share estimate for fiscal year 2028 to ₹24.44 from ₹35.49. These projections assume the commission caps will be fully implemented without any regulatory rollbacks.

Other brokerages have voiced similar concerns. Jefferies has decreased its target price to ₹1,540 from ₹2,050 but retained a Buy rating. It notes that PB Fintech indicated a possible drop in non-life net present value (NPV) to 33-40 percent of current levels if the commission cuts proceed. However, Jefferies expects life insurance NPV to remain stable, supported by higher renewal commissions.

Jefferies also lowered PB Fintech’s valuation multiple by 30 percent to 18 times projected fiscal year 2030 EBITDA, citing uncertainties around take-rates. The brokerage anticipates the company may reduce hiring and marketing spending in the short term.

Morgan Stanley estimates a 60-70 percent decline in the health insurance business’s NPV under the new rules but expects life insurance NPV to hold steady. The firm highlights risks to PB Partners’ POSP business and reports that PB Fintech is exploring new avenues such as manufacturing, reinsurance broking, and potentially acquiring managing general agent (MGA) licenses to adapt to the evolving regulatory environment. Additionally, efforts to reduce losses in Paisabazaar and the company’s UAE operations are underway.

Industry Context and Outlook

The Indian insurance market has been growing steadily, driven by rising awareness and digital adoption. PB Fintech has been a key player in this space, leveraging technology to connect consumers with insurance products efficiently. However, regulatory changes often reshape the competitive landscape and profitability dynamics for intermediaries.

As IRDAI moves forward with these reforms, companies like PB Fintech must adjust their strategies to maintain growth and profitability. The commission caps are intended to make insurance more affordable and transparent for customers but could pressure intermediary revenues. How PB Fintech navigates this transition will be closely watched by investors and industry observers alike.

Other brokers have also adjusted their views, with HSBC downgrading PB Fintech to Hold and setting a target of ₹1,150, while Motilal Oswal maintains a Neutral stance with the same target price. Investors are advised to consult certified financial experts before making decisions based on these developments.